Mounjaro Clinical Trials: What the Research Shows and What It Means for Your Journey

Clinical trials for prescription weight-management medicines are designed to evaluate safety and efficacy in controlled conditions across thousands of participants. They are not a promise of what any one person will experience — they establish whether a medicine is appropriate to prescribe at a population level.

Mounjaro (tirzepatide) trial programme

Tirzepatide was studied in a series of trials known as the SURMOUNT programme. Across these studies, participants received varying doses alongside lifestyle guidance over periods typically lasting more than a year. The trials assessed changes in body weight, as well as metabolic markers. Because tirzepatide acts on both GLP-1 and GIP receptors — a dual mechanism — researchers were examining whether this approach differed from medicines acting on GLP-1 alone. Results were published in peer-reviewed journals and formed part of the regulatory submission to medicines authorities worldwide. You can read factual product information via the electronic Medicines Compendium (eMC), which holds the approved summary of product characteristics.

Wegovy (semaglutide) trial programme

Semaglutide for weight management was studied in the STEP trial programme, a series of large randomised controlled trials. Like the tirzepatide studies, these assessed outcomes over extended periods with lifestyle intervention included in both the medicine and placebo arms. For a broader overview of how Wegovy works and what the evidence base covers, the what Wegovy is and how it works page provides helpful background.

What "trial results" do and do not mean for you

Trial results reflect averages across diverse populations. Some participants lost more than the headline figure; others less. Side-effect profiles reported in trials (commonly nausea, gastrointestinal discomfort, and fatigue) give a general picture, but your individual response is shaped by your starting point, other health factors, diet, activity, and how your dose is managed — all things to discuss with your prescriber or doctor.

If you are weighing up the two medicines, a factual comparison of Mounjaro and Wegovy covers the key differences in mechanism and dose structure. For a broader look at tirzepatide as a medicine, the Mounjaro overview is a good starting point, and you can find equivalent context for semaglutide on the Wegovy overview page.

Clinical trials track outcomes across groups. Your journey is individual — and that is where logging your own data becomes genuinely useful. The patterns that matter most to you are the ones happening in your own body, over your own weeks on treatment.

Tracking what the trials measured, in your own life

Weight change was the primary endpoint in most GLP-1 trial programmes. GLP Trackr's weight and body tracking lets you log your own trend week by week — not as a comparison to trial averages, but as a record of your trajectory. The progress charts and weekly transformation view make it easier to see what is actually happening over months, not just days, which is the timescale the evidence reflects.

Trials also tracked side effects systematically. The side-effect logging feature in GLP Trackr lets you record how you feel after each dose — nausea, fatigue, digestion changes — and spot whether patterns shift as your body adjusts. That log becomes a useful reference when you speak to your prescriber, grounding the conversation in your actual experience rather than memory alone.

Your prescriber is your clinical reference point

Nothing in the published trial data — or on this page — replaces the guidance of the healthcare professional who prescribed your treatment. If you have questions about how trial results apply to your situation, how your progress compares to what was observed in studies, or whether your response is typical, those are exactly the right questions to raise at your next appointment. GLP Trackr helps you arrive at that conversation with clear, organised data rather than rough estimates.

If you experience any symptoms that feel severe, persistent, or unexpected, contact your healthcare professional promptly rather than waiting for a scheduled review.

GLP Trackr is available free on the App Store and Google Play, with a 7-day free trial — log your weight, track side effects, and build the personal picture that clinical averages can never tell you.